About Cytena Exit

cytena's single-cell printer is a unique device for separating, sorting and handling of single biological cells. For the first time this method enables an automated, separation of single cells with high viability and proof of clonality without cross-contamination risks.

Press releases

26. March 2019

EUR 3 million in series A for the growth and development of Cytena GmbH

The High-Tech Gründerfonds (HTGF) and two private investors are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics. EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena's single-cell printers.   Freiburg-based Cytena GmbH successfully completes another financing round. I
29. April 2015

cytena, a University of Freiburg spin-off, received EUR 1.1 million of seed capital from HTGF and a private investor

cytena GmbH, headquartered in Freiburg, has developed a device called single-cell printer to separate single cells. A consortium made up of a private investor and High-Tech Gründerfonds (HTGF), will provide EUR 1.1 million of seed capital. cytena GmbH will use this capital injection primarily to launch its product and to expand its marketing and distribution activities. The single-cell printer, cytena’s newest innovation, is a laboratory device that enables the gentle separation of cells.

Info & Contact

Benjamin Steimle
0049 761 203 732 19
Andre Gross
0049 761 203 732 57


Georges-Koehler-Allee 103
79110 Freiburg

In portfolio

13. Apr 2015 – 05. Aug 2019